Equine Ophthalmology: Common Eye Conditions and Treatment

Horse owners and veterinarians encounter a range of eye conditions that require prompt recognition and appropriate management. The equine eye is anatomically large and exposed, making it vulnerable to trauma, infection, and immune-mediated disease. This article reviews common equine eye conditions, diagnostic techniques, and medical and surgical treatment approaches, with emphasis on practical decision-making for field and clinical settings.

At a Glance: Common Equine Eye Conditions

Anatomy and Physiology of the Equine Eye

The equine eye is among the largest of domestic species, with an axial length of approximately 40 to 45 millimeters. The globe sits in a shallow bony orbit, providing limited protection from external trauma. The cornea is thick and has a prominent endothelial pump mechanism that maintains deturgescence. The iris is heavily pigmented, and the pupil is horizontally oval, allowing a wide field of vision. The lens is large and accommodates poorly, contributing to the horse's reliance on head movement for visual focus.

The retina is holangiotic, meaning it has a complete vascular supply. The optic nerve head is located ventrolateral to the posterior pole. The uveal tract, consisting of the iris, ciliary body, and choroid, is highly vascular and immunologically active. This vascularity predisposes the equine eye to immune-mediated inflammation, particularly equine recurrent uveitis.

The nasolacrimal system drains tears from the medial canthus to the nasal cavity. Obstruction of this system can lead to epiphora and secondary infection. The third eyelid (nictitating membrane) contains lymphoid tissue and a T-shaped cartilage that provides mechanical protection and distributes tears.

Diagnostic Techniques in Equine Ophthalmology

Slit-Lamp Examination

Slit-lamp biomicroscopy provides magnified, illuminated examination of the anterior segment. The slit beam allows assessment of corneal thickness, depth of lesions, anterior chamber depth, and lens clarity. In horses, sedation is often required for thorough examination. The slit-lamp can detect subtle corneal edema, aqueous flare, keratic precipitates, and early cataract formation.

Tonometry

Intraocular pressure (IOP) measurement is essential for diagnosing glaucoma and monitoring uveitis. Rebound tonometry (e.g., TonoVet) is practical in horses because it requires minimal corneal contact and no topical anesthesia. Applanation tonometry (e.g., TonoPen) is also used but requires corneal desensitization. Normal equine IOP ranges from 15 to 30 mmHg, though values vary with head position and restraint.

Fluorescein Staining

Fluorescein sodium dye is applied to the cornea to detect epithelial defects. The dye stains areas where the corneal epithelium is absent, appearing green under cobalt blue light. This test is critical for diagnosing corneal ulcers and assessing healing. A positive stain indicates corneal epithelial loss, while a negative stain does not rule out stromal disease.

Ocular Ultrasonography

Ultrasonography is valuable when the cornea is opaque or when posterior segment assessment is needed. A 7.5 to 10 MHz linear or sector probe is placed on the closed eyelid or directly on the cornea with a standoff. Biometric measurements, including axial length and lens thickness, can be obtained. Ultrasonography helps evaluate lens position, vitreous opacities, retinal detachment, and intraocular masses.

Fundic Examination

Indirect ophthalmoscopy with a 20 or 30 diopter lens provides a wide-field view of the fundus. Direct ophthalmoscopy offers higher magnification but a narrower field. The equine fundus is characterized by a tapetum lucidum in the superior region, a nontapetal region that is darkly pigmented, and a vertically oval optic disc. Examination of the optic disc, retinal vessels, and tapetal and nontapetal regions is essential for detecting chorioretinitis, optic neuritis, and retinal detachment.

Additional Diagnostic Tests

Corneal cytology using a sterile spatula or cytobrush can identify infectious agents and inflammatory cells. Bacterial culture and sensitivity guide antimicrobial therapy. Polymerase chain reaction (PCR) testing can detect viral, bacterial, or fungal DNA. Biopsy of conjunctival or corneal masses is necessary for histopathologic diagnosis.

Equine Recurrent Uveitis

Equine recurrent uveitis (ERU) is the most common cause of blindness in horses. It is an immune-mediated inflammatory condition affecting the uveal tract, with recurrent episodes of active inflammation. The condition has been associated with Leptospira spp. infection, though other triggers include trauma, systemic infection, and autoimmune mechanisms.

Clinical Signs

Active episodes present with blepharospasm, epiphora, photophobia, miosis, aqueous flare, and corneal edema. The iris may appear dull and swollen. Keratic precipitates (inflammatory cell deposits on the corneal endothelium) and fibrin in the anterior chamber are common. Chronic changes include synechiae (adhesions between the iris and lens or cornea), cataract formation, lens luxation, and glaucoma.

Diagnosis

Diagnosis is based on history of recurrent episodes and characteristic clinical findings. Slit-lamp examination reveals anterior chamber inflammation. Tonometry may show low IOP during active inflammation. Fundic examination may reveal chorioretinitis, optic disc edema, or vitreous opacities. Serologic testing for Leptospira antibodies can support the diagnosis, though a positive titer does not confirm causation.

Medical Management

Treatment aims to control inflammation, prevent recurrence, and preserve vision. Topical corticosteroids (e.g., prednisolone acetate) are the mainstay of therapy. Topical atropine relieves ciliary spasm and prevents synechiae formation. Systemic nonsteroidal anti-inflammatory drugs (NSAIDs) such as flunixin meglumine or phenylbutazone reduce inflammation. Systemic corticosteroids are used in severe cases but carry risks of laminitis and immunosuppression.

Immunomodulatory therapy with cyclosporine or sirolimus may reduce recurrence frequency. Subconjunctival or intravitreal injections of corticosteroids or cyclosporine can provide sustained local therapy. Surgical implantation of a cyclosporine-containing sustained-release device is an option for refractory cases.

Surgical Management

In horses with recurrent episodes despite medical therapy, surgical options include vitrectomy and cyclosporine implant placement. Vitrectomy removes inflammatory debris and reduces antigenic stimulation. Cyclosporine implants provide continuous local immunosuppression. These procedures require specialized equipment and expertise.

Prognosis

Prognosis depends on the severity and frequency of episodes. Early and aggressive treatment improves outcomes. Chronic changes such as cataract, glaucoma, and retinal degeneration can lead to vision loss. Horses with ERU require lifelong monitoring and management.

Corneal Ulcers

Corneal ulcers are common in horses due to trauma, foreign bodies, and exposure. The cornea is susceptible to infection because of its exposure and the horse's environment. Ulcers can be classified as superficial, deep, or descemetocele based on depth of tissue loss.

Clinical Signs

Horses with corneal ulcers present with blepharospasm, epiphora, photophobia, and corneal opacity. The ulcer appears as a defect in the corneal epithelium that retains fluorescein stain. Surrounding corneal edema and vascularization indicate inflammation. Deep ulcers may have a white or yellow stromal infiltrate, indicating infection. Descemetoceles appear as a clear or dark bulge in the ulcer base, representing exposure of Descemet's membrane.

Diagnosis

Fluorescein staining confirms the presence and extent of the ulcer. Slit-lamp examination assesses depth and identifies stromal infiltrate. Corneal cytology and culture identify infectious agents. Fungal keratitis should be suspected in ulcers with a white or gray stromal plaque, slow progression, or poor response to antibiotics.

Medical Management

Superficial uncomplicated ulcers are treated with topical broad-spectrum antibiotics (e.g., neomycin-polymyxin-bacitracin, ciprofloxacin). Topical atropine relieves ciliary spasm and pain. Systemic NSAIDs reduce inflammation. A protective hood or patch may be used to prevent self-trauma.

Deep ulcers with stromal loss require more intensive therapy. Topical antibiotics are applied frequently (every 2 to 4 hours). Topical atropine is continued. Systemic NSAIDs and antibiotics are indicated. Antifungal therapy (e.g., voriconazole, natamycin) is added if fungal infection is suspected or confirmed.

Surgical Management

Surgical intervention is indicated for deep ulcers, descemetoceles, and perforations. Conjunctival pedicle grafts provide vascular support and structural integrity. Corneal grafts (keratoplasty) using donor cornea or equine amniotic membrane can restore corneal thickness. Tarsorrhaphy (partial eyelid closure) protects the cornea during healing.

Prognosis

Superficial ulcers typically heal within 5 to 7 days with appropriate therapy. Deep ulcers and those with infection require longer treatment and have a guarded prognosis. Descemetoceles and perforations are emergencies that require immediate surgical intervention. Complications include corneal scarring, pigmentation, and vision impairment.

Cataracts

Cataracts are opacities of the lens that impair vision. They can be congenital, developmental, or acquired. Acquired cataracts are most commonly associated with equine recurrent uveitis, trauma, or aging.

Clinical Signs

Cataracts appear as white or gray opacities within the lens. They may be focal, diffuse, or complete. Vision impairment ranges from mild to complete blindness. The menace response is reduced or absent. Cataracts are classified by location (capsular, cortical, nuclear) and maturity (incipient, immature, mature, hypermature).

Diagnosis

Slit-lamp examination reveals lens opacities and allows assessment of cataract location and density. Indirect ophthalmoscopy evaluates the posterior segment if the cataract is not complete. Ultrasonography is useful when the cataract prevents fundic examination, as it can detect retinal detachment or other posterior segment abnormalities.

Medical Management

No medical therapy reverses cataract formation. Treatment focuses on managing underlying causes, such as uveitis. Topical anti-inflammatory medications may reduce lens-induced uveitis. Horses with cataracts can often function well in familiar environments if vision is not severely impaired.

Surgical Management

Phacoemulsification with intraocular lens implantation is the standard surgical treatment. The procedure requires general anesthesia and specialized equipment. Success rates are high in horses without concurrent ocular disease. Postoperative management includes topical antibiotics, anti-inflammatory medications, and frequent monitoring.

Prognosis

Prognosis for vision after cataract surgery is good in horses without uveitis or glaucoma. Horses with ERU-associated cataracts have a higher risk of complications, including postoperative uveitis, glaucoma, and retinal detachment. Surgery is not recommended for horses with active uveitis or advanced glaucoma.

Glaucoma

Glaucoma is characterized by elevated intraocular pressure that causes optic nerve damage and vision loss. It can be primary or secondary to other ocular diseases such as uveitis, cataract, or intraocular tumors.

Clinical Signs

Early signs include corneal edema, mild mydriasis, and reduced menace response. As the condition progresses, the globe enlarges (buphthalmos), the cornea becomes diffusely edematous, and the optic disc becomes cupped. Horses may show signs of pain, including blepharospasm and photophobia.

Diagnosis

Tonometry reveals elevated IOP, typically above 30 mmHg. Gonioscopy assesses the iridocorneal angle for closure or abnormalities. Fundic examination may show optic disc cupping and retinal atrophy. Ultrasonography can detect buphthalmos and lens luxation.

Medical Management

Topical medications to lower IOP include beta-blockers (e.g., timolol), carbonic anhydrase inhibitors (e.g., dorzolamide), and prostaglandin analogs (e.g., latanoprost). Systemic carbonic anhydrase inhibitors (e.g., acetazolamide) can be used but require monitoring for electrolyte imbalances. Topical anti-inflammatory medications reduce associated uveitis.

Surgical Management

Surgical options include cyclophotocoagulation (laser destruction of ciliary body epithelium) and drainage implant placement. These procedures reduce aqueous humor production or improve outflow. Enucleation is considered for blind, painful eyes that do not respond to medical therapy.

Prognosis

Glaucoma is a progressive condition with a guarded prognosis for vision. Early diagnosis and treatment can slow progression, but many horses eventually lose vision. Pain management is an important aspect of care.

Corneal Stromal Abscess

Corneal stromal abscess is a localized collection of inflammatory cells and infectious agents within the corneal stroma. It often results from a penetrating injury that introduces bacteria or fungi into the stroma, with subsequent epithelial healing that traps the infection.

Clinical Signs

A focal, white to yellow opacity is present in the corneal stroma. Surrounding corneal edema and vascularization are common. The horse shows signs of pain, including blepharospasm and photophobia. The overlying epithelium is intact, so fluorescein staining is negative.

Diagnosis

Slit-lamp examination reveals the depth and location of the abscess. Corneal cytology and culture are obtained after superficial keratectomy or through the abscess wall. PCR testing can identify infectious agents. Ultrasonography may be used to assess depth and rule out posterior segment involvement.

Medical Management

Topical antibiotics and antifungals are used based on culture and sensitivity results. Topical atropine relieves ciliary spasm. Systemic NSAIDs reduce inflammation. Medical therapy alone may be insufficient for deep abscesses.

Surgical Management

Superficial keratectomy removes the abscess and allows topical medications to penetrate. Deeper abscesses may require conjunctival pedicle grafts or corneal grafts. These procedures provide structural support and vascular supply.

Prognosis

Prognosis depends on the depth and infectious agent. Superficial abscesses respond well to keratectomy and medical therapy. Deep abscesses with fungal involvement have a guarded prognosis. Corneal scarring and pigmentation are common sequelae.

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) is the most common ocular tumor in horses. It arises from the conjunctiva, third eyelid, or cornea. Risk factors include ultraviolet light exposure, lack of periocular pigmentation, and age.

Clinical Signs

SCC appears as a raised, irregular, pink to red mass on the conjunctiva, third eyelid, or cornea. It may be ulcerated and bleed easily. The mass can invade the cornea, sclera, and orbit. Metastasis to regional lymph nodes is possible but uncommon.

Diagnosis

Biopsy with histopathologic examination confirms the diagnosis. Cytology from impression smears or fine-needle aspiration can provide preliminary information. Imaging (ultrasonography, computed tomography) assesses local invasion and orbital involvement.

Medical Management

Topical chemotherapy (e.g., 5-fluorouracil, mitomycin C) can be used for superficial lesions. Intralesional chemotherapy (e.g., cisplatin) is an option for larger tumors. Immunomodulatory therapy (e.g., imiquimod) may be effective for early lesions.

Surgical Management

Surgical excision with wide margins is the treatment of choice. Cryotherapy of the tumor bed reduces recurrence. Brachytherapy (radioactive plaque) provides local radiation. Enucleation or exenteration is indicated for extensive orbital involvement.

Prognosis

Prognosis is good for small, superficial tumors that are completely excised. Recurrence is common with incomplete excision. Metastasis is rare but carries a poor prognosis. Regular monitoring for recurrence is essential.

Fungal Keratitis

Fungal keratitis is an infection of the cornea by fungi, most commonly Aspergillus spp. and Fusarium spp. It is more common in warm, humid climates and in horses with corneal trauma or prolonged topical antibiotic or corticosteroid use.

Clinical Signs

Fungal keratitis presents with a white or gray stromal plaque, corneal edema, and vascularization. The lesion progresses slowly compared to bacterial ulcers. The horse shows signs of pain, including blepharospasm and photophobia. Fluorescein staining may be positive or negative depending on epithelial integrity.

Diagnosis

Corneal cytology with Gram stain or fungal stains (e.g., Gomori methenamine silver) reveals fungal hyphae. Culture on Sabouraud agar confirms the species. PCR testing provides rapid identification. Slit-lamp examination assesses depth and extent of stromal involvement.

Medical Management

Topical antifungal medications include voriconazole, natamycin, and miconazole. These are applied frequently (every 2 to 4 hours). Topical atropine relieves ciliary spasm. Systemic NSAIDs reduce inflammation. Topical corticosteroids are contraindicated as they exacerbate fungal infection.

Surgical Management

Superficial keratectomy removes infected tissue and improves drug penetration. Deeper infections may require conjunctival pedicle grafts or corneal grafts. These procedures provide structural support and vascular supply.

Prognosis

Prognosis is guarded, especially for deep infections and those involving Aspergillus spp. Treatment is prolonged, often lasting weeks to months. Complications include corneal perforation, glaucoma, and vision loss.

Ocular Manifestations of Systemic Disease

The eye can reflect systemic disease in horses. Ocular examination may reveal signs of systemic infection, metabolic disorders, or neoplasia.

Leptospirosis

Leptospira infection is strongly associated with equine recurrent uveitis. Ocular signs include uveitis, chorioretinitis, and optic neuritis. Systemic signs include fever, icterus, and renal failure. Diagnosis is based on serology and PCR.

Equine Herpesvirus

Equine herpesvirus (EHV) can cause ocular disease, including conjunctivitis, keratitis, and uveitis. EHV-1 can cause neurologic disease and abortion. Ocular signs may precede systemic signs. Diagnosis is based on PCR and serology.

Streptococcus equi

Streptococcus equi (strangles) can cause conjunctivitis and periorbital abscesses. Ocular signs include epiphora, conjunctival hyperemia, and purulent discharge. Diagnosis is based on culture and PCR.

Neoplasia

Intraocular tumors, including melanoma and lymphoma, can cause uveitis, glaucoma, and vision loss. Diagnosis requires ultrasonography and biopsy. Treatment depends on tumor type and extent.

Neuro-Ophthalmology

Neurologic conditions can affect ocular function. Cranial nerve deficits, brainstem lesions, and optic nerve disease can cause vision loss, abnormal pupillary light reflexes, and strabismus.

Optic Neuritis

Optic neuritis presents with acute vision loss, dilated pupils, and absent pupillary light reflexes. Fundic examination may show optic disc swelling. Causes include infection, inflammation, and trauma. Treatment involves systemic corticosteroids and management of underlying causes.

Horner's Syndrome

Horner's syndrome results from sympathetic nerve damage. Signs include miosis, ptosis, enophthalmos, and third eyelid protrusion. Causes include trauma, infection, and neoplasia affecting the sympathetic chain. Diagnosis is based on clinical signs and pharmacologic testing.

Cranial Nerve Deficits

Cranial nerve deficits can cause strabismus, nystagmus, and facial paralysis. Oculomotor (CN III), trochlear (CN IV), and abducens (CN VI) deficits affect eye movement. Facial nerve (CN VII) paralysis causes eyelid dysfunction and exposure keratitis. Diagnosis requires neurologic examination and imaging.

Ocular Trauma

Ocular trauma is common in horses due to their environment and behavior. Trauma can cause corneal lacerations, hyphema, lens luxation, and globe rupture.

Corneal Lacerations

Corneal lacerations require immediate surgical repair. Small, superficial lacerations may heal with medical therapy. Deep lacerations with aqueous leakage require suturing. Prognosis depends on the size, location, and presence of infection.

Hyphema

Hyphema is blood in the anterior chamber. It results from trauma, uveitis, or coagulopathy. Treatment includes rest, topical atropine, and systemic NSAIDs. Severe hyphema can cause glaucoma and vision loss.

Lens Luxation

Lens luxation occurs when the lens zonules rupture, allowing the lens to move into the anterior chamber or vitreous. It causes glaucoma and vision loss. Treatment involves surgical removal of the lens.

Globe Rupture

Globe rupture is a severe injury that often results in vision loss. Treatment involves enucleation or evisceration. Prompt surgical intervention is required to prevent sympathetic ophthalmia.

Ocular Surgery

Ocular surgery in horses requires specialized equipment and expertise. Common procedures include corneal grafting, cataract surgery, glaucoma surgery, and tumor excision.

Corneal Grafting

Corneal grafting (keratoplasty) is used for deep ulcers, descemetoceles, and perforations. Donor cornea or equine amniotic membrane can be used. The graft is sutured in place and protected with a conjunctival flap or tarsorrhaphy.

Cataract Surgery

Phacoemulsification with intraocular lens implantation is the standard cataract surgery. The procedure requires general anesthesia and a clear cornea. Postoperative management includes topical antibiotics, anti-inflammatory medications, and frequent monitoring.

Glaucoma Surgery

Cyclophotocoagulation reduces aqueous humor production by destroying ciliary body epithelium. Drainage implants improve aqueous outflow. These procedures can lower IOP but may not restore vision.

Tumor Excision

Surgical excision of ocular tumors requires wide margins to reduce recurrence. Cryotherapy, brachytherapy, and topical chemotherapy can be used as adjuncts. Enucleation is indicated for extensive orbital involvement.

Ocular Pharmacology

Topical medications are the mainstay of equine ocular therapy. Systemic medications are used for severe or refractory conditions.

Topical Antibiotics

Topical antibiotics are used for corneal ulcers and infections. Common choices include neomycin-polymyxin-bacitracin, ciprofloxacin, and ofloxacin. Frequency of application depends on the severity of infection.

Topical Antifungals

Topical antifungals include voriconazole, natamycin, and miconazole. These are used for fungal keratitis. Frequency of application is every 2 to 4 hours initially.

Topical Anti-Inflammatory Medications

Topical corticosteroids (e.g., prednisolone acetate) are used for uveitis and noninfectious keratitis. Topical NSAIDs (e.g., flurbiprofen) reduce inflammation and pain. Corticosteroids are contraindicated in corneal ulcers.

Topical Atropine

Topical atropine relieves ciliary spasm and prevents synechiae formation. It causes mydriasis and cycloplegia. Side effects include reduced tear production and colic in some horses.

Systemic Medications

Systemic NSAIDs (e.g., flunixin meglumine, phenylbutazone) reduce inflammation. Systemic corticosteroids are used for severe uveitis but carry risks. Systemic antibiotics and antifungals are used for deep infections.

Records and Measurements

Accurate records are essential for managing equine eye conditions. The following should be documented:

• Signalment: age, breed, sex, coat color, and periocular pigmentation
• History: onset, duration, previous episodes, trauma, systemic illness
• Ocular examination findings: vision assessment, pupillary light reflexes, slit-lamp findings, IOP, fundic examination
• Diagnostic test results: fluorescein staining, cytology, culture, PCR, biopsy
• Treatment plan: medications, frequency, duration, surgical plan
• Monitoring schedule: recheck intervals, parameters to assess
• Outcome: healing, complications, vision status

Common Failure Patterns

Several factors can lead to treatment failure in equine eye conditions:

• Delayed diagnosis: owners may not recognize early signs of eye disease
• Inadequate treatment: insufficient frequency or duration of topical medications
• Poor compliance: difficulty administering medications to horses
• Underlying disease: unrecognized systemic disease or immune-mediated condition
• Drug resistance: bacterial or fungal resistance to antimicrobials
• Surgical complications: infection, graft failure, glaucoma, cataract formation
• Recurrence: ERU and other immune-mediated conditions often recur

Limitations and Professional Escalation Criteria

Veterinarians should recognize when a case exceeds their expertise or resources. Escalation criteria include:

• Vision-threatening conditions: deep corneal ulcers, descemetoceles, perforations, glaucoma
• Refractory uveitis: recurrent episodes despite appropriate medical therapy
• Intraocular tumors: suspected neoplasia requiring biopsy or advanced imaging
• Surgical cases: corneal grafting, cataract surgery, glaucoma surgery
• Neurologic signs: cranial nerve deficits, optic neuritis, Horner's syndrome
• Systemic disease: ocular manifestations of systemic infection or neoplasia

Referral to a veterinary ophthalmologist is recommended for these cases. General practitioners should provide emergency stabilization and then refer.

Welfare and Safety Context

Ocular disease causes significant pain and distress in horses. Prompt recognition and treatment improve welfare outcomes. Horses with vision loss require management adjustments, including safe housing, familiar environments, and consistent routines.

Safety considerations for handlers include proper restraint during examination and treatment. Sedation may be necessary for thorough examination. Protective hoods or patches prevent self-trauma but require monitoring for complications.

Practical Decision Framework for Managing Equine Corneal Ulcers: A Severity-Based Triage and Treatment Protocol

Corneal ulcers are among the most frequently encountered equine ophthalmic emergencies, yet their management varies widely depending on depth, infectious etiology, and progression. A structured decision framework helps veterinarians and horse owners move from initial presentation through treatment selection, monitoring, and escalation. This section provides a practical, severity-based triage system, a record-keeping template, troubleshooting guidance for common complications, and clear criteria for when to involve a veterinary ophthalmologist.

Severity Classification and Initial Triage

Corneal ulcers in horses are best classified by depth, presence of infection, and risk of perforation. This classification directly guides treatment intensity and urgency.

Superficial uncomplicated ulcers involve only the corneal epithelium. They retain fluorescein stain, show minimal stromal edema, and have no visible infiltrate. These ulcers typically result from minor trauma, foreign bodies, or exposure. Pain is present but moderate. Treatment involves topical broad-spectrum antibiotics (e.g., neomycin-polymyxin-bacitracin or ciprofloxacin) applied four to six times daily, topical atropine once or twice daily to relieve ciliary spasm, and systemic nonsteroidal anti-inflammatory drugs (NSAIDs) such as flunixin meglumine (1.1 mg/kg intravenously or orally once daily) for three to five days. A protective hood or patch prevents self-trauma. Recheck in 48 to 72 hours. Most superficial ulcers heal within five to seven days.

Deep ulcers extend into the corneal stroma. They present with significant corneal edema, a visible stromal defect, and often a white or yellow infiltrate indicating infection. Pain is severe, with marked blepharospasm and epiphora. These ulcers require intensive medical therapy and close monitoring. Topical antibiotics should be applied every two to four hours, alternating with topical atropine two to four times daily. Systemic NSAIDs are continued. If a fungal etiology is suspected based on geographic location, climate, or the presence of a gray stromal plaque, add topical antifungal therapy (e.g., voriconazole 1% solution every two to four hours). A corneal cytology sample should be obtained at presentation using a sterile spatula or cytobrush after topical anesthesia. Culture and sensitivity testing guide antimicrobial selection. Recheck every 24 to 48 hours. If the ulcer deepens or the infiltrate expands despite therapy, surgical intervention is indicated.

Descemetoceles represent full-thickness stromal loss with exposure of Descemet's membrane. The ulcer base appears clear or dark, and fluorescein stain does not adhere to Descemet's membrane but stains the surrounding epithelium. These are surgical emergencies. Immediate referral to a veterinary ophthalmologist is recommended. If referral is not immediately available, the eye should be protected with a temporary tarsorrhaphy or a third eyelid flap, topical antibiotics and atropine should be continued, and systemic NSAIDs and antibiotics (e.g., trimethoprim-sulfamethoxazole 30 mg/kg orally twice daily) should be administered. The horse should be transported to a surgical facility as soon as possible.

Corneal perforation presents with a shallow anterior chamber, hypotony, and possible iris prolapse. This is a sight-threatening emergency requiring immediate surgical repair. The eye should be protected with a sterile lubricant and a protective hood. No topical medications should be applied if the globe is open. Systemic antibiotics and NSAIDs are indicated. Emergency referral is mandatory.

Diagnostic Decision Points

The following diagnostic steps should be performed at initial presentation and at each recheck:

1. Fluorescein staining to confirm epithelial loss and assess ulcer margins. A positive stain indicates epithelial defect. A negative stain with a visible stromal opacity suggests a healed epithelial surface over a stromal abscess or a nonulcerative keratitis.

2. Slit-lamp examination to measure ulcer depth, assess stromal infiltrate, and evaluate anterior chamber depth. The slit beam allows precise measurement of corneal thickness loss. A depth greater than 50% of corneal thickness warrants surgical consideration.

3. Corneal cytology to identify infectious agents. Gram stain reveals bacteria (gram-positive cocci or gram-negative rods). Fungal stains (e.g., Gomori methenamine silver) or calcofluor white detect fungal hyphae. Neutrophils indicate active inflammation. Eosinophils may suggest eosinophilic keratitis, which requires different therapy.

4. Tonometry to measure intraocular pressure. Low IOP (below 15 mmHg) suggests active uveitis. High IOP (above 30 mmHg) indicates glaucoma, which can complicate corneal ulcers.

5. Culture and sensitivity for bacterial and fungal organisms. Samples should be obtained from the ulcer base after topical anesthesia using a sterile swab. Transport media appropriate for bacteria and fungi should be used. Results take 48 to 72 hours for bacteria and up to two weeks for fungi.

Record System for Monitoring Ulcer Progression

A standardized record sheet ensures consistent documentation and facilitates communication between veterinarians and owners. The following parameters should be recorded at each examination:

A healing ulcer shows decreasing fluorescein stain uptake, decreasing depth, resolution of infiltrate, and development of corneal vascularization. Vascularization typically appears at the limbus within three to five days and progresses toward the ulcer. The presence of healthy blood vessels indicates a healing response. Lack of vascularization after five days suggests poor healing and may require surgical stimulation.

Troubleshooting Common Complications

Nonhealing ulcer (indolent ulcer) : Some superficial ulcers fail to heal despite appropriate medical therapy. This is often due to loose, nonadherent epithelium at the ulcer margins. Treatment involves debridement of loose epithelium under topical anesthesia using a sterile cotton-tipped applicator or a Kimura spatula. After debridement, a diamond burr or grid keratotomy may be performed to stimulate epithelial adhesion. Topical antibiotics and atropine are continued. Recheck in five to seven days.

Worsening infiltrate despite antibiotics: If the stromal infiltrate expands or becomes more opaque after 48 hours of appropriate antibiotic therapy, consider fungal infection, drug-resistant bacteria, or a corneal stromal abscess. Obtain repeat cytology and culture. Add topical antifungal therapy if not already initiated. Consider surgical intervention (keratectomy) to remove infected tissue and improve drug penetration.

Corneal melting (keratomalacia) : Rapid stromal liquefaction results from collagenase enzymes produced by bacteria (especially Pseudomonas spp.) or by host inflammatory cells. The cornea appears gelatinous and may perforate quickly. Treatment includes topical antibiotics effective against Pseudomonas (e.g., ciprofloxacin or tobramycin every two hours), topical atropine, and systemic NSAIDs. Collagenase inhibitors such as topical EDTA (0.2%) or autologous serum (every one to two hours) may reduce enzymatic degradation. Surgical intervention with a conjunctival pedicle graft is often necessary.

Recurrent ulceration after apparent healing: Some horses develop recurrent corneal ulcers at the same site. This may be due to a retained foreign body, a corneal sequestrum, or an epithelial basement membrane defect. Careful slit-lamp examination and corneal cytology are indicated. Surgical exploration and debridement may be required.

Uveitis secondary to corneal ulcer: Corneal ulcers frequently cause reflex uveitis due to inflammation and pain. Signs include miosis, aqueous flare, and low IOP. Treatment includes topical atropine to dilate the pupil and relieve ciliary spasm, and systemic NSAIDs. Topical corticosteroids are contraindicated in the presence of a corneal ulcer because they impair healing and exacerbate infection.

When to Escalate to a Veterinary Ophthalmologist

General practitioners can manage most superficial and many deep corneal ulcers. However, certain situations warrant referral to a specialist. The Merck Veterinary Manual emphasizes that prompt referral improves outcomes for complex cases. Escalation criteria include:

• Ulcer depth greater than 50% of corneal thickness
• Descemetocele or corneal perforation
• Corneal melting (keratomalacia)
• Lack of improvement after 48 to 72 hours of appropriate medical therapy
• Worsening infiltrate or expanding ulcer despite treatment
• Suspected fungal keratitis that does not respond to topical antifungal therapy within one week
• Recurrent ulceration at the same site
• Corneal stromal abscess deeper than 50% of corneal thickness
• Concurrent glaucoma or lens luxation
• Need for surgical grafting (conjunctival pedicle graft, corneal graft, or amniotic membrane graft)
• Owner unable to administer frequent topical medications

Referral should be arranged as soon as the escalation criterion is identified. The referring veterinarian should provide a complete record of medications administered, diagnostic test results, and the horse's response to therapy. The horse should be transported with a protective hood and continued medical therapy during transport.

Welfare and Safety Considerations

Corneal ulcers cause significant pain. Horses with corneal ulcers show blepharospasm, photophobia, and epiphora. Pain management is an essential component of therapy. Systemic NSAIDs (flunixin meglumine or phenylbutazone) provide analgesia and reduce inflammation. Topical atropine relieves ciliary spasm. In severe cases, systemic opioids (e.g., butorphanol 0.01 to 0.02 mg/kg intravenously) may be used for short-term pain control.

Horses with vision loss from corneal scarring or perforation require management adjustments. They should be housed in familiar, safe environments with consistent routines. Protective hoods prevent self-trauma but must be monitored for pressure sores and adequate ventilation. Horses with monocular vision may startle easily and should be approached from the seeing side.

Safety for handlers is paramount. Horses with eye pain may be head-shy and resistant to treatment. Sedation with xylazine (0.3 to 0.5 mg/kg intravenously) or detomidine (0.01 to 0.02 mg/kg intravenously) facilitates examination and medication administration. A twitch may be used for short procedures. Proper restraint and a calm approach reduce the risk of injury to both horse and handler.

Common Failure Patterns in Ulcer Management

Several factors contribute to treatment failure:

• Inadequate frequency of topical medications: Owners may apply medications only two to three times daily when every-two-hour application is needed. Clear instructions and a written schedule improve compliance.
• Incorrect medication selection: Using topical corticosteroids for a corneal ulcer worsens infection and delays healing. Using antibiotics without antifungal coverage in a region where fungal keratitis is common leads to progression.
• Delayed surgical intervention: Waiting too long to refer a deep ulcer or descemetocele increases the risk of perforation and vision loss.
• Poor owner compliance: Horses that resist treatment may not receive adequate medication. Demonstrating proper technique and using a calm, consistent approach can help.
• Underlying systemic disease: Horses with immune-mediated conditions or chronic uveitis may have delayed corneal healing. Addressing systemic disease improves ocular outcomes.
• Drug resistance: Bacterial or fungal resistance to commonly used medications requires culture and sensitivity testing to guide therapy.

By following a structured decision framework, maintaining detailed records, and recognizing when to escalate care, veterinarians and horse owners can improve outcomes for horses with corneal ulcers and reduce the risk of vision loss.

Frequently Asked Questions

What are the most common eye conditions in horses?

Equine recurrent uveitis, corneal ulcers, and cataracts are among the most common eye conditions. Squamous cell carcinoma and glaucoma are also frequently diagnosed. The prevalence varies with geographic region, management practices, and breed.

How can I tell if my horse has an eye problem?

Signs of eye problems include squinting, tearing, cloudiness, redness, and sensitivity to light. The horse may keep the eye partially or fully closed. Changes in behavior, such as bumping into objects or reluctance to move in unfamiliar areas, may indicate vision loss.

When should I call a veterinarian for an eye problem?

Call a veterinarian immediately if the horse shows signs of pain, corneal opacity, or vision loss. Any eye injury or sudden change in appearance requires prompt evaluation. Delayed treatment can lead to permanent vision loss.

Can equine recurrent uveitis be cured?

Equine recurrent uveitis cannot be cured, but it can be managed. Treatment aims to control inflammation, prevent recurrence, and preserve vision. Immunomodulatory therapy and surgical options can reduce the frequency and severity of episodes.

What is the treatment for a corneal ulcer in a horse?

Treatment depends on the depth and cause of the ulcer. Superficial ulcers are treated with topical antibiotics and atropine. Deep ulcers may require surgical intervention. Fungal ulcers require antifungal therapy. All ulcers require pain management and protection from self-trauma.

Can cataracts in horses be treated with surgery?

Yes, cataracts can be treated with phacoemulsification and intraocular lens implantation. Surgery is most successful in horses without concurrent ocular disease. Postoperative management is intensive and requires frequent monitoring.

What causes glaucoma in horses?

Glaucoma can be primary or secondary. Secondary glaucoma is more common and results from uveitis, cataract, lens luxation, or intraocular tumors. Primary glaucoma is rare in horses.

How can I prevent eye problems in my horse?

Preventive measures include minimizing trauma risk, providing shade to reduce UV exposure, maintaining good stable hygiene, and monitoring for early signs of disease. Regular veterinary examinations can detect problems before they become severe.

Related Veterinary Guides

• California Medical
• Medical Certificate
• Diagnostic Medical Sonography Programs
• Veterinary Clinical Methods Procedures Surgical Interventions
• Swine Respiratory Disease Observation And Diagnostics

References and Further Reading

• www.merckvetmanual.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Neuro-ophthalmology in horses.. The Veterinary clinics of North America. Equine practice, 2011.
• Approach to Immune-mediated Ocular Diseases.. The Veterinary clinics of North America. Equine practice, 2024.
• Equine corneal surgery and transplantation.. The Veterinary clinics of North America. Equine practice, 2004.
• Equine recurrent uveitis: new methods of management.. The Veterinary clinics of North America. Equine practice, 2004.
• Ocular Manifestations of Systemic Disease in the Horse.. The Veterinary clinics of North America. Equine practice, 2017.
• Intraocular Tumors in Horses: Diagnosis, Tumor Classification, Oncologic Assessment and Therapy.. Veterinary sciences, 2025.
• Normograde nasolacrimal placement of an ocular-lavage system for treatment of equine eye diseases.. The Canadian veterinary journal = La revue veterinaire canadienne, 2019.
• [Experiences in the treatment of vascular diseases of the eye fundus with horse chestnut preparations].. Klinische Monatsblatter fur Augenheilkunde und fur augenarztliche Fortbildung, 1954.
• A Critical Review on Aśvavaidyakanighantu: A Lexicon Portion of the Jayadatta's Text on Horse Diseases. Journal of Drug Research in Ayurvedic Sciences, 2019.
• The Treatment of Diseases of the Eye. Nature, 2009.
• Diseases of the brainstem and cranial nerves of the horse: relevant examination techniques and illustrative video segments.. 2011.
• PROPHYLACTIC ENUCLEATION IN SYMPATHETIC OPHTHALMITIS THE EVOLUTION OF AN HEROIC FORM OF TREATMENT To ENUCLEATE an eye as a prophylactic measure against sympathetic ophthalmitis
• Equine ocular ultrasonography: Evaluation of some biometric measurements. Ippologia, 2010.
• Concise Textbook of Equine Clinical Practice Book 5: Nervous System, Eyes, Cardiovascular Disorders and Haemolymphatic System. Concise Textbook of Equine Clinical Practice Book 5 Nervous System Eyes Cardiovascular Disorders and Haemolymphatic System, 2024.
• Equine keratomycosis due to Aspergillus flavus in Argentina. Analecta Veterinaria, 2024.
• Lamelar keratoplasty in dogs using equine amniotic membrane. Clinical and morphological study. Brazilian Journal of Veterinary Research and Animal Science, 2013.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.